BG Medicine, Inc. - FORM 10-K - EX-23.1 - CONSENT OF DELOITTE & TOUCHE LLP - March 30, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - BG Medicine, Inc.Financial_Report.xls
EX-32.1 - CERTIFICATION OF THE CEO AND CFO PURSUANT TO SECTION 906 - BG Medicine, Inc.d262852dex321.htm
EX-31.2 - CERTIFICATION OF THE CFO PURSUANT TO SECTION 302 - BG Medicine, Inc.d262852dex312.htm
EX-10.33 - NON-QUALIFIED STOCK OPTION AGREEMENT - BG Medicine, Inc.d262852dex1033.htm
EX-10.22 - EMPLOYMENT AGREEMENT BY AND BETWEEN THE REGISTRANT AND PIETER MUNTENDAM - BG Medicine, Inc.d262852dex1022.htm
EX-10.21 - EMPLOYMENT AGREEMENT BY AND BETWEEN THE REGISTRANT AND ERIC BOUVIER - BG Medicine, Inc.d262852dex1021.htm
EX-10.36 - NON-EMPLOYEE DIRECTOR COMPENSATION POLICY - BG Medicine, Inc.d262852dex1036.htm
EX-10.11.2 - AMENDMENT TO THE PARTICIPATION AGREEMENT - BG Medicine, Inc.d262852dex10112.htm
EX-10.12.2 - AMENDMENT TO THE PARTICIPATION AGREEMENT - BG Medicine, Inc.d262852dex10122.htm
EX-10.14.2 - AMENDMENT TO THE PARTICIPATION AGREEMENT - BG Medicine, Inc.d262852dex10142.htm
10-K - FORM 10-K - BG Medicine, Inc.d262852d10k.htm
EX-31.1 - CERTIFICATION OF THE CEO PURSUANT TO SECTION 302 - BG Medicine, Inc.d262852dex311.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No. 333-172208 on Form S-8 of our report dated March 30, 2012, relating to the consolidated financial statements of BG Medicine, Inc., appearing in this Annual Report on Form 10-K of BG Medicine, Inc. for the year ended December 31, 2011.

 

/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 30, 2012

BG Medicine, Inc. Reports